Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
Immune checkpoint inhibitors (ICIs) have completely changed the treatment of cancer, and they also can cause multiple organ immune-related adverse reactions (irAEs). Among them, rheumatic irAE is less common, mainly including inflammatory arthritis, rheumatic myalgia/giant cell arteritis, inflammato...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2020/2640273 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832546936165498880 |
|---|---|
| author | Yan Xiao Lin Zeng Qinglin Shen Zhiyong Zhou Zhifang Mao Qin Wang Xiquan Zhang Yingliang Li Weirong Yao |
| author_facet | Yan Xiao Lin Zeng Qinglin Shen Zhiyong Zhou Zhifang Mao Qin Wang Xiquan Zhang Yingliang Li Weirong Yao |
| author_sort | Yan Xiao |
| collection | DOAJ |
| description | Immune checkpoint inhibitors (ICIs) have completely changed the treatment of cancer, and they also can cause multiple organ immune-related adverse reactions (irAEs). Among them, rheumatic irAE is less common, mainly including inflammatory arthritis, rheumatic myalgia/giant cell arteritis, inflammatory myopathy, and Sjogren’s syndrome. For oncologists, rheumatism is a relatively new field, and early diagnosis and treatment is very important, and we need to work closely with experienced rheumatologists. In this review, we focused on the incidence, clinical characteristics, and treatment strategies of rheumatic irAE. |
| format | Article |
| id | doaj-art-43b0135eb7c5454f913cdc4db42ba203 |
| institution | Kabale University |
| issn | 2314-8861 2314-7156 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-43b0135eb7c5454f913cdc4db42ba2032025-02-03T06:46:36ZengWileyJournal of Immunology Research2314-88612314-71562020-01-01202010.1155/2020/26402732640273Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint InhibitorsYan Xiao0Lin Zeng1Qinglin Shen2Zhiyong Zhou3Zhifang Mao4Qin Wang5Xiquan Zhang6Yingliang Li7Weirong Yao8Department of Oncology, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Jiangxi, ChinaDepartment of Oncology, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Jiangxi, ChinaDepartment of Oncology, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Jiangxi, ChinaDepartment of Oncology, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Jiangxi, ChinaDepartment of Oncology, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Jiangxi, ChinaDepartment of Oncology, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Jiangxi, ChinaDepartment of Oncology, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Jiangxi, ChinaDepartment of General Surgery, The First Affiliated Hospital of Nanchang University, Jiangxi, ChinaDepartment of Oncology, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Jiangxi, ChinaImmune checkpoint inhibitors (ICIs) have completely changed the treatment of cancer, and they also can cause multiple organ immune-related adverse reactions (irAEs). Among them, rheumatic irAE is less common, mainly including inflammatory arthritis, rheumatic myalgia/giant cell arteritis, inflammatory myopathy, and Sjogren’s syndrome. For oncologists, rheumatism is a relatively new field, and early diagnosis and treatment is very important, and we need to work closely with experienced rheumatologists. In this review, we focused on the incidence, clinical characteristics, and treatment strategies of rheumatic irAE.http://dx.doi.org/10.1155/2020/2640273 |
| spellingShingle | Yan Xiao Lin Zeng Qinglin Shen Zhiyong Zhou Zhifang Mao Qin Wang Xiquan Zhang Yingliang Li Weirong Yao Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors Journal of Immunology Research |
| title | Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors |
| title_full | Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors |
| title_fullStr | Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors |
| title_full_unstemmed | Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors |
| title_short | Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors |
| title_sort | diagnosis and treatment of rheumatic adverse events related to immune checkpoint inhibitors |
| url | http://dx.doi.org/10.1155/2020/2640273 |
| work_keys_str_mv | AT yanxiao diagnosisandtreatmentofrheumaticadverseeventsrelatedtoimmunecheckpointinhibitors AT linzeng diagnosisandtreatmentofrheumaticadverseeventsrelatedtoimmunecheckpointinhibitors AT qinglinshen diagnosisandtreatmentofrheumaticadverseeventsrelatedtoimmunecheckpointinhibitors AT zhiyongzhou diagnosisandtreatmentofrheumaticadverseeventsrelatedtoimmunecheckpointinhibitors AT zhifangmao diagnosisandtreatmentofrheumaticadverseeventsrelatedtoimmunecheckpointinhibitors AT qinwang diagnosisandtreatmentofrheumaticadverseeventsrelatedtoimmunecheckpointinhibitors AT xiquanzhang diagnosisandtreatmentofrheumaticadverseeventsrelatedtoimmunecheckpointinhibitors AT yingliangli diagnosisandtreatmentofrheumaticadverseeventsrelatedtoimmunecheckpointinhibitors AT weirongyao diagnosisandtreatmentofrheumaticadverseeventsrelatedtoimmunecheckpointinhibitors |